"5520" Strategy of Shenwei Pharmaceutical Group

At the arrival of the new economic era, we have formulated the "5520" strategy, that is, to build five platforms within five years and realize sales revenue of 2 billion yuan. These five platforms are production technology platform, marketing platform, scientific management platform (including information technology), scientific research and development platform and capital operation platform, which push the enterprise to a brand-new development stage. In the next five years, we will invest 1 100 million yuan to build a green industrial park of traditional Chinese medicine, which integrates medicinal materials cultivation, scientific research, production, medical treatment and health care, form a diversified health industry system, and rapidly enhance the international competitiveness of enterprises. At the same time, seize the opportunity to promote Chinese medicine to the west, let the world know about Chinese medicine, let Chinese medicine go global, and benefit human health!